Heerdt AS - Search Results

1

Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma.

Port ER, Fey J, Gemignani ML, Heerdt AS, Montgomery LL, Petrek JA, Sacchini V, Van Zee KJ, Borgen PI, Cody HS 3rd. Port ER, et al. Among authors: heerdt as. J Am Coll Surg. 2002 Aug;195(2):167-72. doi: 10.1016/s1072-7515(02)01268-1. J Am Coll Surg. 2002. PMID: 12168962

2

Calcium glucarate as a chemopreventive agent in breast cancer.

Heerdt AS, Young CW, Borgen PI. Heerdt AS, et al. Isr J Med Sci. 1995 Feb-Mar;31(2-3):101-5. Isr J Med Sci. 1995. PMID: 7744577 Review.

3

Breast conservation therapy for invasive carcinoma of the breast.

Borgen PI, Heerdt AS, Moore MP, Petrek JA. Borgen PI, et al. Among authors: heerdt as. Curr Probl Surg. 1995 Mar;32(3):191-248. doi: 10.1016/s0011-3840(05)80016-4. Curr Probl Surg. 1995. PMID: 7882704 Free article. Review. No abstract available.

4

The Special Surveillance Breast Program: a model of intervention for women at high risk for breast cancer.

Gross RE, Van Zee KJ, Heerdt AS. Gross RE, et al. Among authors: heerdt as. J N Y State Nurses Assoc. 1997 Dec;28(4):9-12. J N Y State Nurses Assoc. 1997. PMID: 9564357

5

Current status of tamoxifen use: An update for the surgical oncologist.

Heerdt AS, Borgen PI. Heerdt AS, et al. J Surg Oncol. 1999 Sep;72(1):42-9. doi: 10.1002/(sici)1096-9098(199909)72:1<42::aid-jso13>3.0.co;2-e. J Surg Oncol. 1999. PMID: 10477879 Review.

6

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

Robson M, Levin D, Federici M, Satagopan J, Bogolminy F, Heerdt A, Borgen P, McCormick B, Hudis C, Norton L, Boyd J, Offit K. Robson M, et al. J Natl Cancer Inst. 1999 Dec 15;91(24):2112-7. doi: 10.1093/jnci/91.24.2112. J Natl Cancer Inst. 1999. PMID: 10601383

7

Palpable breast masses: is there a role for percutaneous imaging-guided core biopsy?

Liberman L, Ernberg LA, Heerdt A, Zakowski MF, Morris EA, LaTrenta LR, Abramson AF, Dershaw DD. Liberman L, et al. AJR Am J Roentgenol. 2000 Sep;175(3):779-87. doi: 10.2214/ajr.175.3.1750779. AJR Am J Roentgenol. 2000. PMID: 10954467

8

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?

Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, Heerdt A, Montgomery L, Paglia M, Petrek JA, Cody HS, Van Zee KJ. Klauber-DeMore N, et al. Ann Surg Oncol. 2000 Oct;7(9):636-42. doi: 10.1007/s10434-000-0636-2. Ann Surg Oncol. 2000. PMID: 11034239

9

Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.

Olson JA Jr, Fey J, Winawer J, Borgen PI, Cody HS 3rd, Van Zee KJ, Petrek J, Heerdt AS. Olson JA Jr, et al. Among authors: heerdt as. J Am Coll Surg. 2000 Dec;191(6):593-9. doi: 10.1016/s1072-7515(00)00732-8. J Am Coll Surg. 2000. PMID: 11129806

10

Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.

Boolbol SK, Fey JV, Borgen PI, Heerdt AS, Montgomery LL, Paglia M, Petrek JA, Cody HS 3rd, Van Zee KJ. Boolbol SK, et al. Among authors: heerdt as. Ann Surg Oncol. 2001 Jan-Feb;8(1):20-4. doi: 10.1007/s10434-001-0020-x. Ann Surg Oncol. 2001. PMID: 11206219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters